These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35985823)

  • 1. Herpes Viruses in the Baltimore Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive Performance, and Plasma Biomarkers.
    Duggan MR; Peng Z; An Y; Kitner Triolo MH; Shafer AT; Davatzikos C; Erus G; Karikkineth A; Lewis A; Moghekar A; Walker KA
    Neurology; 2022 Oct; 99(18):e2014-e2024. PubMed ID: 35985823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
    Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
    Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of liver disease with brain volume loss, cognitive decline, and plasma neurodegenerative disease biomarkers.
    Peng Z; Duggan MR; Dark HE; Daya GN; An Y; Davatzikos C; Erus G; Lewis A; Moghekar AR; Walker KA
    Neurobiol Aging; 2022 Dec; 120():34-42. PubMed ID: 36115133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment.
    Asken BM; VandeVrede L; Rojas JC; Fonseca C; Staffaroni AM; Elahi FM; Lindbergh CA; Apple AC; You M; Weiner-Light S; Brathaban N; Fernandes N; Boxer AL; Miller BL; Rosen HJ; Kramer JH; Casaletto KB
    J Int Neuropsychol Soc; 2022 Jul; 28(6):588-599. PubMed ID: 34158138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
    Mattsson-Carlgren N; Salvadó G; Ashton NJ; Tideman P; Stomrud E; Zetterberg H; Ossenkoppele R; Betthauser TJ; Cody KA; Jonaitis EM; Langhough R; Palmqvist S; Blennow K; Janelidze S; Johnson SC; Hansson O
    JAMA Neurol; 2023 Apr; 80(4):360-369. PubMed ID: 36745413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
    Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
    JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Changes in Blood Biomarkers of Clinical Alzheimer Disease in a Biracial Population Sample.
    Rajan KB; McAninch EA; Aggarwal NT; Barnes LL; Wilson RS; Weuve J; DeCarli CS; Evans DA
    Neurology; 2023 Feb; 100(8):e874-e883. PubMed ID: 36446595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes.
    Marks JD; Syrjanen JA; Graff-Radford J; Petersen RC; Machulda MM; Campbell MR; Algeciras-Schimnich A; Lowe V; Knopman DS; Jack CR; Vemuri P; Mielke MM;
    Alzheimers Res Ther; 2021 Dec; 13(1):199. PubMed ID: 34906229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline.
    Ebenau JL; Pelkmans W; Verberk IMW; Verfaillie SCJ; van den Bosch KA; van Leeuwenstijn M; Collij LE; Scheltens P; Prins ND; Barkhof F; van Berckel BNM; Teunissen CE; van der Flier WM
    Neurology; 2022 Mar; 98(13):e1315-e1326. PubMed ID: 35110378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.
    Li X; Yucel R; Clervius H; Kamalakar K; Zetterberg H; Blennow K; Zhang J; Adimora A; Collins LF; Fischl M; Kassaye S; Maki P; Seaberg E; Sharma A; Vance D; Gustafson DR
    JAMA Netw Open; 2023 Nov; 6(11):e2344194. PubMed ID: 38019518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses.
    Rouch L; Virecoulon Giudici K; Cantet C; Guyonnet S; Delrieu J; Legrand P; Catheline D; Andrieu S; Weiner M; de Souto Barreto P; Vellas B;
    Am J Clin Nutr; 2022 Dec; 116(6):1492-1506. PubMed ID: 36253968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy.
    Rabin JS; Pruzin J; Scott M; Yang HS; Hampton O; Hsieh S; Schultz AP; Buckley RF; Hedden T; Rentz D; Johnson KA; Sperling RA; Chhatwal JP
    Neurology; 2022 Jul; 99(3):e270-e280. PubMed ID: 35473760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
    Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
    Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy.
    Svenningsson AL; Stomrud E; Palmqvist S; Hansson O; Ossenkoppele R
    Alzheimers Res Ther; 2022 Oct; 14(1):144. PubMed ID: 36192766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between personality and plasma biomarkers of astrogliosis and neuronal injury.
    Terracciano A; Walker K; An Y; Luchetti M; Stephan Y; Moghekar AR; Sutin AR; Ferrucci L; Resnick SM
    Neurobiol Aging; 2023 Aug; 128():65-73. PubMed ID: 37210782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.